← Back to Search

Educational App for Hepatitis C

N/A
Recruiting
Led By Yu-Hsiang Hsieh, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
HCV positive without HCV RNA information
18 years or older
Must not have
Younger than 18 years of age
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 months
Awards & highlights

Summary

This trial will test the impact of a personalized educational app on people's knowledge and motivation related to hepatitis C care.

Who is the study for?
This trial is for adult patients at Johns Hopkins Hospital's Emergency Department who have tested positive for Hepatitis C but don't yet have HCV RNA testing information. It excludes minors, those unable to consent, prisoners, critically ill individuals, and patients with altered mental status.
What is being tested?
The study tests an educational app designed to improve understanding of Hepatitis C among ED patients. The app provides personalized liver health information and aims to enhance patient knowledge and motivation regarding their care continuum from diagnosis through treatment.
What are the potential side effects?
Since this trial involves the use of an educational app rather than a medical intervention or drug, traditional physical side effects are not expected. However, participants may experience stress or anxiety related to learning about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am positive for hepatitis C but don't have RNA details.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I am unable to understand and give consent for treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Linkage to care rate (days)
Secondary study objectives
Change in HCV knowledge as assessed by True/False survey questions
Change in level of motivation to receive HCV care as assessed by a Likert Scale
Change in perceived barriers to HCV care as assessed by a Likert Scale
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient-Centered Electronic App GroupExperimental Treatment1 Intervention
Patients assigned to the intervention group will receive individualized reports regarding patients' HCV disease progress/liver fibrosis staging by a Fibrosis-4 score using the personalized HCV educational app. The individualized report will also include comprehensive knowledge to fill the gap on general HCV information, natural history of the disease, and care and treatment, if there is any, as well as level of interest in receiving HCV care based on patients' response to the short survey questionnaires on the tablet. Patients will also receive the investigators' HCV program pamphlet regarding HCV infection and disease progression, treatment, as well as information regarding clinics available for HCV care in Baltimore. Patients will receive standard of care, routine HCV LTC services from the investigators' ED HCV LTC program staff.
Group II: Reference GroupActive Control1 Intervention
Patients assigned to the reference group will receive the investigators' current 'static' standard of care HCV program pamphlet regarding HCV infection and disease progression, treatment, as well as information regarding clinics available for HCV care in Baltimore City. Patients will also receive standard of care, routine HCV LTC services from the investigators' ED HCV LTC program staff.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,307 Previous Clinical Trials
14,861,601 Total Patients Enrolled
18 Trials studying Hepatitis C
154,549 Patients Enrolled for Hepatitis C
Yu-Hsiang Hsieh, PhDPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
400 Total Patients Enrolled
1 Trials studying Hepatitis C
200 Patients Enrolled for Hepatitis C

Media Library

Patient-Centered Electronic App Clinical Trial Eligibility Overview. Trial Name: NCT04162938 — N/A
Hepatitis C Research Study Groups: Patient-Centered Electronic App Group, Reference Group
Hepatitis C Clinical Trial 2023: Patient-Centered Electronic App Highlights & Side Effects. Trial Name: NCT04162938 — N/A
Patient-Centered Electronic App 2023 Treatment Timeline for Medical Study. Trial Name: NCT04162938 — N/A
~98 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top